Lung cancer accounts for around 27-percent of all cancer deaths worldwide, according to the International Association for the Study of Lung Cancer (IASLC). That’s more deaths than colon, breast, and prostate cancers combined, adds the source.
Luckily, medical scientists have been hard at work over the years working on more effective therapies in light of a cure. In solidarity with Lung Cancer Awareness Month in November, let’s look at six targeted therapies for lung cancer that are making a difference for patients…
The American Cancer Society notes that cancerous lung tumors develop their own blood vessels in order to grow. However, there are some drugs that have been developed that directly target this process—and often have less severe side effects than chemotherapy, according to the source.
These drugs for non-small cell lung cancer (the most common form of lung cancer) include Bevacizumab (Avastin) and Ramucirumab (Cyramza). The role of these drugs is to inhibit the formation of blood vessels in the tumor, essentially helping to starve them out. Chemotherapy is sometimes used in conjunction with these drug therapies, notes the cancer society.